Overview

MiMedx Group, Inc. ("MiMedx Group") is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products. The company is successfully emerging from a development-focused start-up phase into a fully integrated operating company with expertise to capitalize on its science and technology and its capacity to generate sales growth and profitability.

Our platform technologies, AmnioFix^®, EpiFix^®, HydroFix^® and CollaFix^®, have such a vast number of potential applications in treating traumatized tissue and structures that it is too difficult to accurately quantify. MiMedx Group is focused on commercializing multiple applications of all three technologies. In parallel, we are seeking strategic relationships to more rapidly commercialize our technologies.

Shareholder Letters

March 29, 2011 2011 year end shareholder letter

Dec 20, 2010 December shareholder letter

Jul 23, 2010 July shareholder letter

Apr 27, 2010 April shareholder letter

Mar 30, 2010 March shareholder letter

Nov 17, 2009 November shareholder letter

Aug 17, 2009 August shareholder letter